TABLE 1.
Univariate analysis of risk factors for hospitalization among patients with cancer and SARS‐CoV‐2 infection (N = 433)
| Variable | Not hospitalized, N = 233 (%) | Hospitalized, N = 200 (%) | cOR (CI 95%) | p value |
|---|---|---|---|---|
| Age, median (IQR) a | 52 (41–61) | 57 (48–67) | 1.31 (1.14–1.50) | <0.01 |
| Sex | ||||
| Women | 154 (67) | 114 (57) | 0.65 (0.44–0.97) | 0.03 |
| Smoking | 70 (30) | 67 (34) | 1.17 (0.78–1.76) | 0.44 |
| Comorbidities | ||||
| Diabetes mellitus | 42 (18) | 51 (26) | 1.56 (0.98–2.47) | 0.06 |
| Hypertension | 64 (27) | 67 (34) | 1.33 (0.88–2.00) | 0.17 |
| Obesity (BMI ≥30) | 74 (32) | 61 (31) | 0.94 (0.63–1.42) | 0.78 |
| Cancer type (n = 423) | ||||
| Hematologic malignancy | 31 (13) | 51 (26) | 2.25 (1.37–3.70) | <0.01 |
| Stage of cancer (n = 302) | ||||
| Advanced disease | 77 (33) | 93 (47) | 1.83 (1.22–2.75) | 0.03 |
| Chemotherapy 30 days | ||||
| No chemotherapy | 168 (72) | 131 (66) | 1 | |
| Cytotoxic chemotherapy | 52 (22) | 57 (29) | 1.41 (0.90–2.18) | 0.13 |
| Immunotherapy or targeted therapy | 13 (6) | 12 (6) | 1.18 (0.52–2.68) | 0.69 |
Abbreviations: BMI, body mass index. cOR, crude odds ratio; IQR, interquartile range; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.
a
Age was categorized into 10‐years intervals.